Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Both the courts and the public seem confused about sexual harassment—what it is, how it functions, and what sorts of behaviors are actionable in court. Theresa M. Beiner contrasts perspectives from social scientists on the realities of workplace sexual harassment with the current legal standard. When it comes to sexual harassment law, all too often courts (and employers) are left in the difficult position of grappling with vague legal standards and little guidance about what sexual harassment is and what can be done to stop it. Often, courts impose their own stereotyped view of how women and men “ought” to behave in the workplace. This viewpoint, social science reveals, is frequently out of sync with reality.As a legal scholar who takes social science seriously, Beiner provides valuable insight into what behaviors people perceive as sexually harassing, why such behavior can be characterized as discrimination because of sex, and what types of workplaces are more conducive to sexually harassing behavior than others. Throughout, Beiner offers proposals for legal reform with the goal of furthering workplace equality for both men and women.

Sexual harassment --- Law and the social sciences --- Harcèlement sexuel --- Droit et sciences sociales --- Law and legislation --- Social aspects --- Droit --- Aspect social --- Law and the social sciences -- United States. --- Sexual harassment -- Law and legislation -- Social aspects -- United States. --- Law - U.S. --- Law, Politics & Government --- Labor Law - U.S. --- Harcèlement sexuel --- Social sciences and law --- Sexual harassment in the workplace --- Workplace sexual harassment --- Social sciences --- Sociological jurisprudence --- Harassment --- Sex role in the work environment --- United States --- Sociological aspects --- Law and social sciences --- Beiner. --- because. --- behavior. --- behaviors. --- characterized. --- conducive. --- discrimination. --- harassing. --- insight. --- into. --- legal. --- more. --- others. --- people. --- perceive. --- provides. --- scholar. --- science. --- seriously. --- sex. --- sexually. --- social. --- such. --- takes. --- than. --- types. --- valuable. --- what. --- workplaces.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.

Humanities --- Social interaction --- virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.

Humanities --- Social interaction --- virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine